Home > Insider Trading > Filing (0001552781-16-001819)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1125345	Macrogenics Inc	MGNX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1587150	Lynn Cilinski	9704 Medical Center Drive Rockville MD 20850	Vp, Controller And Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-07-01	8,922	$0.94	10,845	No	4	M	Direct
Common Stock	Disposition	2016-07-01	8,922	$27.22	1,923	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2016-07-01	4,501	$0.00	4,501	$0.94
Common Stock	Employee Stock Option (right to buy)	Disposition	2016-07-01	4,421	$0.00	4,421	$0.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,989	2008-07-05	2018-01-05	No	4	M	Direct
7,989	2009-07-11	2019-01-10	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This transaction was executed in multiple trades at prices ranging from $26.795 to $27.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.